Prevention of enteric fever in travellers with typhoid conjugate vaccines
Author(s) -
Carl Britto,
Celina Jin,
Katherine Theiss-Nyland,
Andrew J. Pollard
Publication year - 2018
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/tay120
Subject(s) - typhoid fever , medicine , enteric fever , typhoid vaccine , virology , conjugate , conjugate vaccine , salmonella typhi , immunization , immunology , antigen , escherichia coli , mathematical analysis , mathematics , biochemistry , chemistry , gene
The 2018 WHO position paper on typhoid vaccines indicates preference for the use of new generation typhoid conjugate vaccines over existing parenteral Vi-polysaccharide (Vi-PS) and oral attenuated Ty21a vaccines
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom